John Treace
CEO / Founder

Treace Medical Concepts specializes in 3D bunion correction through its proprietary Lapiplasty® technique, which offers a reproducible approach to three-plane bunion correction using advanced instrumentation. The company addresses the need for effective and minimally invasive surgical solutions in foot and ankle procedures, enabling patients to return to weight-bearing activities in less than two weeks.
CEO / Founder
Traditional bunion correction surgery often fails to address the root cause of the deformity, leading to recurrence and continued pain for patients. Existing techniques may not fully correct the bunion in all three anatomical planes, resulting in suboptimal outcomes and limitations in weight-bearing activities.
Treace Medical Concepts offers the Lapiplasty® system, a 3D bunion correction procedure designed to address the instability at the root of the bunion in all three dimensions. The Lapiplasty® procedure utilizes advanced, patented instrumentation and surgical techniques to reproducibly correct the deformity, stabilize the joint, and allow for faster return to weight-bearing. The company also provides the Adductoplasty® system for midfoot realignment, SpeedPlate™ implants for rapid compression fixation, and various plating systems designed for the tarsometatarsal joint. Treace's minimally invasive systems, such as Micro-Lapiplasty®, Mini-Adductoplasty™, Nanoplasty™, and Percuplasty™, aim to reduce incision sizes and improve patient outcomes.
The primary audience includes foot and ankle surgeons seeking reproducible and effective solutions for 3D bunion correction and related foot deformities.